MGMT and glioblastoma: In our systematic review focusing on recent clinical trials (conducted in the last 10 years), we included 14 studies/1231 patients and investigated the association of MGMT promoter methylation with OS outcomes in GBM patients, irrespective of therapeutic intervention.